CEIOPS' Advice for Level 2 Implementing ... - EIOPA - Europa
CEIOPS' Advice for Level 2 Implementing ... - EIOPA - Europa
CEIOPS' Advice for Level 2 Implementing ... - EIOPA - Europa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
C.6. The individual elements sketched in the previous paragraphs should be<br />
calculated by using the following bases of calculation:<br />
(a) For the increased morbidity/disability inception rates during the first<br />
year, the product of the following factors:<br />
• the total disability capital at risk (in year one) and<br />
• an undertaking-specific expected average rate of transition from<br />
healthy to sick over the first year (weighted by the sum assured/<br />
annual payment).<br />
(b) For the increased morbidity/disability inception rates during all subsequent<br />
years, the product of the following factors:<br />
• the total disability capital at risk in year two,<br />
• an undertaking-specific expected average rate of transition from<br />
healthy to sick over the second year (weighted by the sum<br />
assured/annual payment),<br />
• the modified duration of the liability cash-flows diminished by<br />
one and<br />
• the Projected Disability Increase (1.1 ((n-2)/2) ), cf. the assumption<br />
that the average disability rate of the portfolio, due to age,<br />
increases over the period corresponding to the length of the<br />
duration with 10 per cent a year.<br />
(c) With respect to the risk that the duration of claims is greater than<br />
expected, 20 per cent the product of the following factors:<br />
• technical Provisions <strong>for</strong> contracts subject to longevity risk,<br />
• an undertaking-specific expected termination rate (i.e. average<br />
rate of transition from sick to healthy/dead over the next year),<br />
• the modified duration of the liability cash-flows and<br />
• the Projected Disability Increase (1.1 ((n-1)/2) ).<br />
101/112<br />
© CEIOPS 2010